Dopamine receptor D1–Type-1 angiotensin II receptor heterodimer (AT1-D1R)

The Dopamine receptor D1–Type-1 angiotensin II receptor (AT1–D1R) heterodimer is a specialized protein complex found predominantly in the renal proximal tubules, where it serves as a key regulator of systemic blood pressure and sodium balance (Zeng et al., 2003, PMID: 12642496). Within this heterodimer, the Dopamine receptor D1 (D1R) and the Type-1 angiotensin II receptor (AT1R) engage in direct physical interaction and functional cross-talk, typically resulting in the D1R-mediated inhibition of AT1R signaling (Jose et al., 2008, PMID: 18277151). This antagonistic relationship is vital for promoting natriuresis—the excretion of sodium in the urine—which counteracts the sodium-retaining and hypertensive effects of Angiotensin II. In pathological states such as essential hypertension, the coupling between these receptors is often disrupted, leading to impaired sodium handling and increased vascular resistance (Armando et al., 2015, PMID: 25925971). Pharmacological intervention targeting this complex often involves D1R agonists like fenoldopam or AT1R antagonists like losartan to restore normal renal function and lower blood pressure. Consequently, the AT1–D1R heterodimer represents a sophisticated target for cardiovascular and renal therapies, offering a more nuanced approach than targeting either receptor in isolation.

Other names

AT1R-D1R complexD1R-AT1R heteromerAngiotensin II type 1 receptor-Dopamine D1 receptor heterodimerRenal AT1-D1R complex

Activation of the Dopamine receptor D1 within the heterodimer promotes the heterologous desensitization and internalization of the Type-1 angiotensin II receptor, which inhibits Angiotensin II-stimulated sodium reabsorption in the renal proximal tubule (Zeng et al., 2003, PMID: 12642496).